Anti NMDAR autoimmune encephalitis: outcomes

Evidence-based neurology checklist on anti nmdar autoimmune encephalitis: outcomes: Outcomes There is a good recovery in 75% of cases Relapses occur in 15% of cases The mortality is 7-11% Predictors of relapses Predictors of intensive care-dependent refractory disease (RI-NMDARE) Predictors of…

Outcomes

  • There is a good recovery in 75% of cases
  • Relapses occur in 15% of cases
  • The mortality is 7-11%

Predictors of relapses

Predictors of intensive care-dependent refractory disease (RI-NMDARE)

Predictors of mortality

References

  1. Dalmau J, Glelchman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case serious and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098.
  2. Ciano-Petersen NL, Villagrán-García M, Muñiz-Castrillo S, et al. Relapses in anti-NMDAR encephalitis: clinical characterization and predictive features. Neurol Neuroimmunol Neuroinflamm 2025; 12:e200421.
  3. Elosua-Bayes I, Dumez P, Benaiteau M, et al. Clinical features and biomarkers associated with intensive care-dependent refractory NMDAR encephalitis: a retrospective cohort study. Neurol Neuroimmunol Neuroinflamm 2026; 13:e200552.

Related checklists

Loading...